Omeros Corp OMER:NASDAQ

Last Price$2.81NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/20/22

Today's Change-0.07(2.43%)
Bid (Size)$2.75 (30)
Ask (Size)$4.56 (1)
Day Low / High$2.76 - 3.00
Volume1.2 M
  • Latest Stories
  • Commentary and Analysis
Omeros Says Results of Study Evaluating Narsoplimab Published in Journal of Clinical Oncology
11:49AM ET 4/20/2022 MT Newswires

Omeros (OMER) said Wednesday the results of a study evaluating the efficacy and safety of its investigational drug narsoplimab to treat hematopoietic stem...

Omeros Q4 Adjusted Loss Widens in Wake of Omidria Sale
5:21PM ET 3/01/2022 MT Newswires

Omeros (OMER) reported a Q4 adjusted net loss of $0.37 per share late Tuesday, compared with a loss of $0.36 per share in Q3. The biopharmaceutical...

Omeros Confirms Submission of Briefing Package to FDA Following Narsoplimab Concerns
4:05AM ET 1/20/2022 MT Newswires

Omeros (OMER) said late Wednesday it has submitted a briefing package to the US Food and Drug Administration after the agency raised concerns about...

--Cantor Fitzgerald Adjusts Omeros' Price Target to $20 From $34, Reiterates Overweight Rating
10:28AM ET 1/18/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Omeros Closes $1 Billion Sale of Omidria Eye Medication
10:08AM ET 12/23/2021 MT Newswires

Omeros Corp. (OMER) said Thursday it has closed the sale of Omidria eye medication to Rayner Surgical in a deal valued in excess of $1 billion. The...

Sector Update: Health Care Stocks Trailing Thursday Field Higher
4:00PM ET 12/02/2021 MT Newswires

Health care stocks were ending off Thursday's pace, with the NYSE Health Care Index rising 0.5% this afternoon while the SPDR Health Care Select Sector ETF...

Sector Update: Health Care Stocks Higher But Log Lowest Gains Among Sectors
1:41PM ET 12/02/2021 MT Newswires

Health care stocks were trending higher this afternoon, with the NYSE Health Care Index rising 0.5% while the SPDR Health Care Select Sector ETF (XLV) was...

Omeros to Sell OMIDRIA Franchise to Rayner Surgical in Deal Valued at Over $1 Billion; Shares Rise Pre-Bell
8:03AM ET 12/02/2021 MT Newswires

Biopharmaceutical firm Omeros (OMER) said Thursday it has agreed to sell the OMIDRIA franchise to Rayner Surgical Group in a deal valued at over $1...

--HC Wainwright Adjusts Price Target on Omeros to $12 From $19, Maintains Buy Rating
11:15AM ET 10/19/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Top Midday Decliners
2:15PM ET 10/18/2021 MT Newswires

Revance Therapeutics (RVNC) said late Friday that the Food and Drug Administration declined to approve its biologics license application for...